Q0220 was retired on Dec 12, 2024

CMS ended Q0220 after Dec 12, 2024. Don’t report it for later dates of service. Look up the drug for its current code.

Look up tixagevimab and cilgavimab

Code

CMS HCPCS file
HCPCS codeQ0220
Billing unit300 mg
Descriptor
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
Short descriptor
Tixagev and cilgav, 300mg
Code set
HCPCS Level II, maintained by CMS
Effective
Dec 13, 2024

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Find the NDC

Med-Code hasn’t mapped Q0220 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.

Search NDCs for tixagevimab and cilgavimab

Q0220: common questions

Is Q0220 a CPT code?
No. Q0220 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What is one billing unit of Q0220?
One unit of Q0220 is 300 mg, as stated in the code's descriptor. Units to report = dose given ÷ 300 mg. J-code billing units.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in